1 Stock for the
Marijuana Boom CEO Bets $1.1B on 1 Pot Stock This pot stock could be like buying
Amazon for $3.19. fool.com OPEN
Ad closed by
Report this ad Why this ad?
Seen this ad multiple times
Ad covered content
Not interested in this ad
Ad was inappropriate
We’ll try not to show that ad again
Ad closed by MRFR is Leading Research Firm who recently published “Chronic Kidney Disease Market Research Report” which includes Growth Study, Regional Analysis, Top Industry Players Formation, Major Drivers, Upcoming Trends and Forecast to 2023.
Chronic Kidney Disease Market – Synopsis
Market Research Future (MRFR)’s latest study reveals that the global chronic kidney disease market is set to expand moderately at a CAGR of 5.2% during the forecast period 2017 to 2023.
The investments into development of new treatments coupled with rising prevalence of kidney diseases are expected to drive the growth of the market in the next couple of years.
GET PREMIUM SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/5744
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the U.S., has stated that nearly 14% of the overall population is affected by chronic kidney diseases.
An upsurge in the number of biopsy procedures is witnessed in the recent times and is likely to perpetuate in the forthcoming years. This, in turn, is expected to have a positive influence on the proliferation of the chronic kidney disease market.
Furthermore, the rising burden of diabetes has intensified the preventive care treatment for kidney diseases. It is anticipated to have a strong impact on the growth of the market. Other factors responsible for the growth of the market are rising healthcare expenditure, developing healthcare sector, growing research & development activities, technological advancements in the healthcare sector, etc.
Detailed Market Segmentation
By diagnosis, the chronic kidney disease market is segmented into blood test, urine test, imaging test, and kidney biopsy.
By treatment, the global chronic kidney disease market has been segmented into drugs, dialysis, and kidney transplant. The drugs segment is further sub-segmented into ace inhibitors, angiotensin-ii receptor blockers, calcium channel blockers, beta-blockers, and erythropoiesis-stimulating agents.
By indication, the chronic kidney disease market is segmented into Type 1 or Type 2 diabetes, high blood pressure, polycystic kidney disease, and others.
By end-user, the global chronic kidney disease market has been segmented into hospitals and clinics, diagnostic centers, and others.
Chronic Kidney Disease Market – Regional Analysis
By region, the Global Chronic Kidney Disease Market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas is poised to exhibit a healthy growth throughout the forecast period. The growth is attributable to the increasing patient pool, rising demand for alternative treatments, extensive use of diagnostic tests, etc.
Europe is an important growth pocket of the chronic kidney disease market. The factors responsible for favoring the expansion of the regional market include rising awareness about risk factors associated with kidney diseases, booming medical device industry, exponential diabetic population, huge investments in the medical device sector, etc. Additionally, rising government support and funding for research & development is further likely to augment the regional chronic kidney disease market over the assessment period.
Asia Pacific is projected to strike a relatively higher CAGR owing to the large-scale prevalence of diabetes and cardiovascular diseases. The growth of the region can be ascribed to the presence of developed healthcare infrastructure, rapid advancements in the healthcare sector, the presence of skilled healthcare professionals, etc.
The Middle East & Africa accounts for the least share of the chronic kidney disease market. It is due to the limited technological penetration and lack of awareness.
BROWSE PREMIUM RESEARCH REPORT @ https://www.marketresearchfuture.com/reports/chronic-kidney-disease-market-5744
Some of the key players profiled in the report are Beckman Coulter, F. Hoffmann-La Roche Ltd, Abbott, Siemens, Sysmex, ACON Laboratories, Inc., URIT Medical, 77 Elektronika, Randox Laboratories, Teva Pharmaceutical Industries Ltd., Amgen Inc., Nova Biomedical, ARKRAY, OPTI Medical, AstraZeneca Plc, Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc, AbbVie Inc., F. Hoffmann-La Roche Ltd., and Kissei Pharmaceutical Co. Ltd
In May 2018, Baxter, a healthcare company, inked a partnership with International Society of Nephrology to advance awareness and therapy for patients with chronic kidney disease in low and middle-income countries.
In July 2018, Otsuka, a pharmaceutical company, acquired renal denervation device developed by ReCor Medical.
Some Points from Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope of the Study2.2.1 Research Objective2.2.2 Assumptions2.2.3 LimitationsChapter 3. Research Methodology3.1 Introduction3.2 Primary Research3.3 Secondary Research3.4 Market Size EstimationChapter 4. Market Dynamics4.1 Drivers4.2 Restrains4.3 Opportunities4.4 Challenges4.5 Macroeconomic Indicators4.6 Technology Trends & AssessmentChapter 5. Market Factor Analysis5.1 Porters Five Forces Analysis5.1.1 Bargaining Power of SuppliersTOC Continued… Avail Attractive Discount @ https://www.marketresearchfuture.com/check-discount/5744 About Us: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.Media Contact Company Name: Market Research Future Contact Person: Abhishek Sawant Email: Send Email Phone: +1 646 845 9312 Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar City: Pune State: Maharashtra Country: India Website: https://www.marketresearchfuture.com/reports/big-data-as-a-service-market-1209
Click here to view original web page at 2019 Chronic Kidney Disease Market Strategic Study sharing spotlight in Global Industry | Market Estimates & Forecast